Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation

AI Briefing

• – Daiichi Sankyo sets fiscal 2026-2030 business plan with a focus on oncology leadership and innovation, aiming for 2.3 trillion yen in oncology revenue by 2030 and becoming a global top five oncology company by 2035.